Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6279587rdf:typepubmed:Citationlld:pubmed
pubmed-article:6279587lifeskim:mentionsumls-concept:C0005821lld:lifeskim
pubmed-article:6279587lifeskim:mentionsumls-concept:C0001443lld:lifeskim
pubmed-article:6279587lifeskim:mentionsumls-concept:C0018330lld:lifeskim
pubmed-article:6279587lifeskim:mentionsumls-concept:C1819041lld:lifeskim
pubmed-article:6279587pubmed:issue1lld:pubmed
pubmed-article:6279587pubmed:dateCreated1982-6-14lld:pubmed
pubmed-article:6279587pubmed:abstractTextIn intact human platelets activated by thrombin, diacylglycerol is produced with the concomitant disappearance of phosphatidylinositol (PI). This reaction is associated with phosphorylation of a protein having a molecular weight of about 40,000 (40 K protein) and serotonin release. All the reactions are inhibited in a parallel manner by incubation of platelets with either dibutyryl cyclic AMP or 8-bromocyclic GMP, prior to the stimulation by thrombin. The inhibition of these reactions is inversely related to phosphorylation of another group of platelet proteins. Since Ca2+-activated, phospholipid-dependent protein kinase (C-Kinase) is activated by diacylglycerol and is responsible for 40 K protein phosphorylation (Kawahara, Y., Takai, Y., Minakuchi, R., Sano, K., & Nishizuka, Y. (1980) Biochem. Biophys. Res. Commun. 97, 309-317), the results suggest that in platelets both cyclic AMP and cyclic GMP may serve as inhibitors of C-Kinase by counteracting the receptor-linked PI breakdown probably through the actions of cyclic nucleotide-dependent protein kinases.lld:pubmed
pubmed-article:6279587pubmed:languageenglld:pubmed
pubmed-article:6279587pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6279587pubmed:citationSubsetIMlld:pubmed
pubmed-article:6279587pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6279587pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6279587pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6279587pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6279587pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6279587pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6279587pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6279587pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6279587pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6279587pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6279587pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6279587pubmed:statusMEDLINElld:pubmed
pubmed-article:6279587pubmed:monthJanlld:pubmed
pubmed-article:6279587pubmed:issn0021-924Xlld:pubmed
pubmed-article:6279587pubmed:authorpubmed-author:SanoKKlld:pubmed
pubmed-article:6279587pubmed:authorpubmed-author:NishizukaYYlld:pubmed
pubmed-article:6279587pubmed:authorpubmed-author:TakaiYYlld:pubmed
pubmed-article:6279587pubmed:authorpubmed-author:KaibuchiKKlld:pubmed
pubmed-article:6279587pubmed:issnTypePrintlld:pubmed
pubmed-article:6279587pubmed:volume91lld:pubmed
pubmed-article:6279587pubmed:ownerNLMlld:pubmed
pubmed-article:6279587pubmed:authorsCompleteYlld:pubmed
pubmed-article:6279587pubmed:pagination403-6lld:pubmed
pubmed-article:6279587pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:6279587pubmed:meshHeadingpubmed-meshheading:6279587-...lld:pubmed
pubmed-article:6279587pubmed:meshHeadingpubmed-meshheading:6279587-...lld:pubmed
pubmed-article:6279587pubmed:meshHeadingpubmed-meshheading:6279587-...lld:pubmed
pubmed-article:6279587pubmed:meshHeadingpubmed-meshheading:6279587-...lld:pubmed
pubmed-article:6279587pubmed:meshHeadingpubmed-meshheading:6279587-...lld:pubmed
pubmed-article:6279587pubmed:meshHeadingpubmed-meshheading:6279587-...lld:pubmed
pubmed-article:6279587pubmed:meshHeadingpubmed-meshheading:6279587-...lld:pubmed
pubmed-article:6279587pubmed:meshHeadingpubmed-meshheading:6279587-...lld:pubmed
pubmed-article:6279587pubmed:meshHeadingpubmed-meshheading:6279587-...lld:pubmed
pubmed-article:6279587pubmed:meshHeadingpubmed-meshheading:6279587-...lld:pubmed
pubmed-article:6279587pubmed:meshHeadingpubmed-meshheading:6279587-...lld:pubmed
pubmed-article:6279587pubmed:meshHeadingpubmed-meshheading:6279587-...lld:pubmed
pubmed-article:6279587pubmed:meshHeadingpubmed-meshheading:6279587-...lld:pubmed
pubmed-article:6279587pubmed:meshHeadingpubmed-meshheading:6279587-...lld:pubmed
pubmed-article:6279587pubmed:year1982lld:pubmed
pubmed-article:6279587pubmed:articleTitleCounteraction of calcium-activated, phospholipid-dependent protein kinase activation by adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in platelets.lld:pubmed
pubmed-article:6279587pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6279587pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6279587lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6279587lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6279587lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6279587lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6279587lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6279587lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6279587lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6279587lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6279587lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6279587lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6279587lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6279587lld:pubmed